Journal
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 88A, Issue 4, Pages 849-857Publisher
WILEY
DOI: 10.1002/jbm.a.31919
Keywords
poly(methyl methacrylate) (PMMA) particles; DNA vaccine; gene gun; cervical cancer
Funding
- National Science Council of the Republic of China
Ask authors/readers for more resources
DNA vaccination is a novel immunization strategy that possesses many potential advantages over other vaccine strategies. One of the major difficulties hindering the clinical application of DNA vaccination is the relative poor immunogenicity of DNA vaccines. Poly(methyl methacrylate) (PMMA) is a synthetic polymer approved by the Food and Drug Administration for certain human clinical applications such as the bone cement. In vivo, PMMA particles are phagocytosable and have the potential to initiate strong immune responses by stimulating the production of inflammatory cytokines. In this study, we synthesized a series of PMMA particles (PMMA 1-5) with different particle sizes and surface charges to test the feasibility of implementing such polymer particles for DNA vaccination. To our knowledge, this is the first report to show that the gene gun can deliver DNA vaccine by propelling PMMA particles mixed with plasmid DNA for cervical cancer. It was found that PMMA 4 particles (particle size: 460 +/- 160 nm, surface charge: +11.5 +/- 1.8 mV) stimulated the highest level of TNF-alpha production by macrophages in vitro and yielded the best result of antitumor protection in vivo. Therefore, our results possess the potential for translation and implementation of polymer particles in gene gun delivering DNA vaccination. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 849-857, 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available